OFFICIAL PUBLICATION OF

by its subsidiary APPco

Research Roundup

Debbie Rigby 02/02/2021

Debbie Rigby rounds up the latest in research news Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes A large systematic review and network meta-analysis of 764 randomised controlled trials has concluded that SGLT-2 inhibitors and GLP-1 receptor agonists reduced cardiovascular and renal outcomes in patients with type 2

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Did wave of protest fail to break?

Well, It either complies with requirements or it does not. No amount of torches and pitchforks will alter the facts…

Michael Khoo

Transaction fees drive MedAdvisor growth

Is there any other way to actually access project stop now? It all seems a bit dodgy that you have…

Andrew Crowley

Did wave of protest fail to break?

The pharmacy guild is too busy making large donations to the major political parties to further its own agenda and…

kitty penfold

‘I was just painted as a criminal’: CWH profiling incident slammed

That's not what I'm saying. What I'm saying is when it is in dispute whether an item has been paid…

Bart Pharm

Research Roundup

Previous The debate goes on

Next Time running out on APP2021 Super Early Bird savings

Clinical tips: Timing!

Clinical tips: Movement disorders

Clinical tips: Worms, Worms, Worms

Intranasal Midazolam for at home use

MENU

Previous The debate goes on

Next Time running out on APP2021 Super Early Bird savings

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.